PRESS RELEASE published on 05/06/2025 at 17:40, 8 months 23 days ago VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expanding Sales Network, New Product Launches, & Growth in Pharmacy and Online Sales Valbiotis reports strong start to the year with expanding sales network, new product launches, and growth in pharmacy and online sales. Company roadmap on track, strategic targets confirmed Valbiotis Online Sales Product Launches Sales Network Pharmacy
BRIEF published on 04/18/2025 at 18:00, 9 months 11 days ago Valbiotis: Results of the General Meeting of April 18, 2025 Valbiotis General Assembly Food Supplements Natural Health Sébastien Peltier
BRIEF published on 04/18/2025 at 17:59, 9 months 11 days ago Valbiotis: Report on the General Meeting of April 18, 2025 General Meeting Valbiotis Food Supplements Natural Health Sébastien Peltier
BRIEF published on 04/07/2025 at 15:05, 9 months 22 days ago VALBIOTIS SA: Monthly update on voting rights and share capital Share Capital Voting Rights Euronext Growth Financial Regulation Valbiotis SA
BRIEF published on 03/31/2025 at 17:45, 9 months 29 days ago Valbiotis announces its Combined General Meeting on April 18, 2025 Shareholders General Meeting Valbiotis Resolutions La Rochelle
PRESS RELEASE published on 03/31/2025 at 17:40, 9 months 29 days ago VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships Valbiotis strengthens its foothold in pharmacies through strategic partnerships with Apothical and Solution Réseau d'Achat, optimizing distribution and reinforcing its position in the pharmacy market Strategic Partnerships Valbiotis Distribution Pharmacies Pharmacy Market
BRIEF published on 03/18/2025 at 09:56, 10 months 11 days ago Valbiotis: Monthly update on capital and voting rights Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF published on 03/18/2025 at 09:55, 10 months 11 days ago Total Number of Voting Rights and Shares of Valbiotis SA Share Capital Voting Rights Actions Transparency Euronext Growth
BRIEF published on 03/17/2025 at 17:45, 10 months 12 days ago Valbiotis Introduces Cholesterol Management Alternative Amid Regulatory Changes Regulation Valbiotis Lipidrive Cholesterol Management Red Yeast Rice
PRESS RELEASE published on 03/17/2025 at 17:40, 10 months 12 days ago VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management in response to changing regulations. Learn about Valbiotis®PRO Cholesterol Valbiotis Lipidrive Health Supplements Cholesterol Management Red Yeast Rice
Published on 01/30/2026 at 02:15, 2 hours 56 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 5 hours 11 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 6 hours 11 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 10 hours 26 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 11 hours 11 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/30/2026 at 04:30, 40 minutes ago A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 1 hour 35 minutes ago Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 5 hours 3 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 8 hours 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 8 hours 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 18:00, 11 hours 11 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 11 hours 26 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 11 hours 26 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 10:07, 19 hours 3 minutes ago Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech